Barclays initiated coverage of Teladoc Health with an Overweight rating and $26 price target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on TDOC:
- Teladoc’s Tangella sells over $600K in company stock
- Teladoc Health to Participate in Upcoming Investor Conference
- Unusually active option classes on open December 21st
- Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08
- Teladoc call volume above normal and directionally bullish